Antibodies Treatment:Cancer
Antibody marks the cancer cell and makes it easier for the immune system to find. The monoclonal antibody drug rituximab (Rituxan) attaches to a specific protein (CD20) found only on B cells, one type of white blood cell. Certain types of lymphomas arise from these same B cells. monoclonal antibodies can also function by attenuating hyperactive growth signals neo angiogenesis. A monoclonal antibody can be conjugated to a radioactive particle that will ensure directed delivery to the cancer cell and slow and long release of the radiation, hence maximizing chances of positive outcome and minimizing non-specific damaging exposure to radiation.
- Immuno Stimulatory Monoclonal Antibodies for Cancer Therapy
- Clinical Practice on Current Monoclonal Antibodies Cancer Therapies
- Hybridoma Technology for Production of Monoclonal Antibodies
- Radiation Induced Immunogenic Modulation to Enhance T-Cell and Monoclonal Antibody Therapy of Cancer
- Impact of Epigenetic Changes on Cervical Cancer Progression
- Skin Cancer Immunology: Profiling the Inflammatory Response
Related Conference of Antibodies Treatment:Cancer
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergy and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
Philadelphia USA
2nd International Conference and Exhibition on Antibodies
July 14-15 2016
Berlin Germany
2nd International Conference on
July 21-22 2016
Dubai UAE
7th Global Summit on Cancer Therapy
October 05-07 2015
Brisbane Australia
Global Summit on Melanoma and Carcinoma
July 14-15 2016
Paris France
The World Cancer congress
31 Oct-3 Nov 2016
Baltimore USA
3rd International Conference and Exhibition on Clinical Cellular Immunology
September 29-October 01 2014
Chicago USA
4th World Congress on Cancer Science Therapy
October 20-22 2014
Chicago USA
2nd International Conference on Prostate Cancer and Treatment
May 05-07 2016
Birmingham UK
World Congress on Breast Cancer
August 03-05 2015
London UK
3rd World Congress on Women s Health and Breast Cancer
October 03-05 2016
Paris France
World Cancer Congress
3-6 December 2014
Brisbane Australia
Global Summit on Melanoma and Carcinoma
July 14-15 2016
Kings Dock Waterfront Liverpool UK
NCRI Cancer Conference
1-4 November 2015
Amsterdam Netherlands
10th European Breast Cancer Conference EBCC-10
9-11 March 2016
Fontainebleau Miami Beach 4441 Collins Avenue Miami Beach FL 33140
33rd Annual Miami Breast Cancer Conference
10 13 March 2016
Melbourne Australia
World Congress On Controversies In Breast Cancer 2015
October 22 -24 2015
New York NY United States
International Congress On Hematologic Malignancies
October 22- 24 2015
Argentina
VI Inter American Oncology Conference
October 8-9 2015
Belfast
United Against Cancer
8-10 June
Mykonos Greece
The 32nd Conference on Monoclonal Antibodies And Cancer Stem Cells
24th -26th June 2015
Mykonos Greece
5th International Conference on Notch Targeting in Cancer
24th -26th June 2015
Yokohama Japan
18th World Conference on Lung Cancer
October 15 18 2017
Vienna Austria
17th World Conference on Lung Cancer
December 4-7 2016
Chiang Mai Thailand
IASLC Asia Pacific Lung Cancer Conference APLCC 2016
May 13-16 2016
Santa Monica California
16th Annual Targeted Therapies of Lung Cancer Meeting
February 17 - 20 2016
Geneva Switzerland
European Lung Cancer Conference 2016
April 13 - 16 2016
Canada
International Conference on Cancer Nursing ICCN 2015
July 8 - 11 2015
Houston Texas
The 10th Urologic Oncology Conference
November 20-21 2015
Houston Texas
Oncologic Emergency Medicine Conference
November 13-14 2015
Vienna Austria
The European Cancer Congress 2015
25-29 September 2015
Antibodies Treatment:Cancer Conference Speakers
Recommended Sessions
- Brain Tumors
- Tumor Cells
- Tumors
- Antibodies Treatment:Cancer
- Cancer biomarkers
- Cancer clinical trials
- Cancer Immunology & Immunotherapy
- Cancer micro and immuno environment
- Cancer Research
- Cancer vaccines
- Combining Cancer Immunotherapies
- Engineered T-Cell Therapy
- Immune checkpoint inhibitors
- Immune System- Tumors
- Immuno-Oncology studies
- Immunotherapy - tumors
- Immunotherapy Monitoring
- Novel Approaches
- Tumor biology
- Tumor immunology
- Tumor immunotherapy research
- Tumor markers and drug targetting
- Tumorigenesis
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)